Related Experiment Video
Updated: Jun 2, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Drug-induced impulse control disorders in Parkinson's disease
1Department of Psychiatry and Psychotherapy, HSK Wiesbaden, Ludwig-Erhard-Strasse 100, 65199 Wiesbaden, Germany.
Journal of Neurology
|May 12, 2011
Summary
Excessive dopamine therapy for Parkinson's disease can lead to behavioral issues like dopamine dysregulation syndrome and impulse control disorders, including compulsive behaviors. These side effects highlight the need for careful treatment monitoring in Parkinson's patients.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder primarily treated with dopamine replacement therapy (DRT).
- DRT, while effective, carries risks of neurological and behavioral side effects due to dopamine receptor stimulation.
Purpose of the Study:
- To summarize the behavioral disturbances associated with dopamine replacement therapy in Parkinson's disease.
- To identify common impulse control disorders and related conditions linked to aberrant dopamine receptor stimulation.
Main Methods:
- Literature review of studies on Parkinson's disease treatment and side effects.
- Analysis of reported cases of behavioral disturbances in patients undergoing dopamine therapy.
Main Results:
- Excessive or aberrant dopamine receptor stimulation can precipitate behavioral disturbances.
- Key conditions include dopamine dysregulation syndrome, punding, and impulse control disorders (ICDs).
- Common ICDs encompass compulsive buying, pathological gambling, binge eating, hypersexuality, and compulsive reckless driving.
Conclusions:
- Behavioral disturbances are significant potential side effects of dopamine replacement therapy in Parkinson's disease.
- Awareness and monitoring of dopamine dysregulation syndrome and impulse control disorders are crucial for patient management.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.